Riskpilot← Back to searchSign inGet full accessALCYON ApS
APSDissolvedCVR 31863678Mågevej 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20141 employees
Revenue 2024
DKK 913K
+14% vs 2023
EBITDA margin
-20.0%
+25% vs 2023
Equity ratio
13.5%
Financial strength
Net profit 2024
DKK -158K
+20% vs 2023
| Revenue | DKK 913K | +14% |
| EBITDA | DKK -182K | +25% |
| Net profit | DKK -158K | +20% |
| Total assets | DKK 1,6M | +114% |
| Equity | DKK 211K | -43% |
| Employees | 1 | — |
Legal name
ALCYON ApS
CVR number
31863678
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. april 2014
Share capital
DKK 150.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem.
Address
Mågevej 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -104 | -17 | -45 | 61 | -372 | -309 | 69 | 767 | 923 | 800 | 913 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -533 | -587 | -0 | -0 |
| EBITDA | -104 | -17 | -45 | 61 | -372 | -309 | 69 | 234 | 335 | -243 | -182 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -15 | -17 | -0 | -0 |
| EBIT | -104 | -17 | -45 | 61 | -372 | -309 | 69 | 219 | 319 | -243 | -182 |
| Net financials | -1 | -3 | -3 | -6 | 55 | -0 | -1 | -4 | -1 | -9 | -20 |
| Profit before tax | -105 | -20 | -48 | 56 | -317 | -309 | 69 | 215 | 318 | -252 | -202 |
| Tax | -21 | -4 | -11 | 12 | -70 | 18 | -0 | -0 | 46 | -55 | -44 |
| Net profit | -84 | -16 | -38 | 43 | -247 | -327 | 69 | 215 | 271 | -197 | -158 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 269 | 268 | 231 | 1.440 | 466 | 280 | 623 | 1.504 | 2.160 | 734 | 1.566 |
| Equity | -4 | -20 | -58 | -14 | -261 | -589 | -520 | 295 | 566 | 369 | 211 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 273 | 288 | 289 | 1.455 | 727 | 869 | 1.143 | 1.209 | 1.589 | 364 | 1.348 |
| Total debt | 273 | 288 | 289 | 1.455 | 727 | 869 | 1.143 | 1.209 | 1.589 | 364 | 1.348 |
EBITDA margin
-20.0%
This company
15.8%
Market median
-227% vs market
20142024
Equity ratio
13.5%
This company
38.2%
Market median
-65% vs market
20142024
Return on equity
-74.8%
This company
18.4%
Market median
-507% vs market
20142024
Net profit margin
-17.3%
This company
8.1%
Market median
-314% vs market
20142024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20142024
Debt / equity
6.41×
This company
0.62×
Market median
-934% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-04-18 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MG Management | Management | 2018 | — | — |
MR Management | Management | 2014 | — | — |
KM Management | Management | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lilsig Holding ApS | Company | 20.0% | 20.0% | 2021 |
JAMT ApS | Company | 33.3% | 33.3% | 2021 |
WELLDANA A/S | Company | 66.7% | 66.7% | 2018 |
PKM HOLDING ApS | Company | 25.0% | 25.0% | 2021 |
able nordic a/s | Company | 100.0% | 100.0% | 2023 |
GP2008HOLDING ApS | Company | 10.0% | 10.0% | 2021 |
Holdingselskabet af 21.04.2008 ApS | Company | 33.3% | 33.3% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ALCYON ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maja Gro Lilsig | Management | 0 companies |
| Martin Riis Holm | Management | 0 companies |
| Kim Madsen | Management | 0 companies |
| Martin Pedersen | Board of Directors | 0 companies |
| Lars Philip Knudsen | Chairman | 0 companies |
| Janus Hygom | Board of Directors | 0 companies |
| Line Damgaard Johansen | Board of Directors | 0 companies |
| Bo Pedersen | Board of Directors | 0 companies |